Relations (1)

related 2.00 — strongly supporting 3 facts

Serotonergic psychedelics are being investigated as potential therapeutic interventions for depression, as evidenced by their role in promoting neuroplasticity [1], their re-emergence as a treatment interest [2], and their demonstrated potential in managing neuropsychiatric disorders like depression [3].

Facts (3)

Sources
The Montreal model: an integrative biomedical-psychedelic ... frontiersin.org Frontiers in Psychiatry 1 fact
claimKetamine and serotonergic psychedelics are re-emerging as potential treatments for depression, generating considerable interest.
Psychedelics and Consciousness: Distinctions, Demarcations, and ... ouci.dntb.gov.ua David B Yaden, Matthew W Johnson, Roland R Griffiths, Manoj K Doss, Albert Garcia-Romeu, Sandeep Nayak, Natalie Gukasyan, Brian N Mathur, Frederick S Barrett · Oxford University Press 1 fact
claimSerotonergic psychedelics induce altered states of consciousness and have shown potential for treating neuropsychiatric disorders, including depression and addiction.
Neuroimaging in psychedelic drug development: past, present, and ... nature.com Nature 1 fact
claimSerotonergic psychedelics may treat depression through the mechanism of neuroplasticity.